Cargando…

10 Year Biochemical Failure Free Survival of Men with CD82 Positive Primary Circulating Prostate Cells Treated by Radical Prostatectomy

OBJECTIVE: The biological characteristics of circulating prostate cells (CPCs) are probably more important than their mere presence. CD82 is a tumor suppressor, we present the outcome of radical prostatectomy (RP) in men with CD82 positive CPCs. METHODS AND PATIENTS: consecutive men treated with RP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Nigel P, Aedo, Socrates, Fuentealba, Cynthia, Reyes, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103576/ https://www.ncbi.nlm.nih.gov/pubmed/29936782 http://dx.doi.org/10.22034/APJCP.2018.19.6.1577

Ejemplares similares

Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016)

Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2018)

Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
por: Murray, Nigel P, et al.
Publicado: (2018)

The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2020)

Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
por: Murray, Nigel P, et al.
Publicado: (2019)

Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer
por: Murray, Nigel P, et al.
Publicado: (2022)

The presence of secondary circulating prostate tumour cells determines the risk of biochemical relapse for patients with low- and intermediate-risk prostate cancer who are treated only with external radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2018)

Secondary Circulating Prostate Cells Predict Biochemical Failure in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease
por: Murray, Nigel P., et al.
Publicado: (2013)

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017)

The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
por: Murray, Nigel P, et al.
Publicado: (2020)

Primary Circulating Prostate Cells Are Not Detected in Men with Low Grade Small Volume Prostate Cancer
por: Murray, Nigel P., et al.
Publicado: (2014)

Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications
por: Murray, Nigel P., et al.
Publicado: (2013)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Clinical and biochemical outcomes of men undergoing radical prostatectomy or radiation therapy for localized prostate cancer
por: Schreiber, David, et al.
Publicado: (2015)

The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy
por: Cho, Sung Yong, et al.
Publicado: (2016)

Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer
por: Kok, Dieuwertje E. G., et al.
Publicado: (2010)

Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy
por: Kim, Dong Soo, et al.
Publicado: (2015)

Is it truly outrageous to consider radical prostatectomy for men with metastatic prostate cancer?
por: Gautam, Gagan
Publicado: (2014)

Effectiveness of epidural versus alternate analgesia for pain relief after radical prostatectomy and correlation with biochemical recurrence in men with prostate cancer
por: Mir, Maria C, et al.
Publicado: (2013)

Predictive Value of Neutrophil to Lymphocyte Ratio in the Diagnosis of Significant Prostate Cancer at Initial Biopsy: A Comparison with Free Percent Prostate Specific Antigen, Prostate Specific Antigen Density and Primary Circulating Prostate Cells
por: Murray, Nigel P, et al.
Publicado: (2019)

Prediction of biochemical failure in localized carcinoma of prostate after radical prostatectomy by neuro-fuzzy
por: Goyal, Neeraj Kumar, et al.
Publicado: (2007)

Prostate Cancer Biochemical Recurrence Rates After Robotic-Assisted Laparoscopic Radical Prostatectomy
por: Ginzburg, Serge, et al.
Publicado: (2012)

Management of biochemical recurrence after radical prostatectomy for prostate cancer: A case report
por: Shen, Jiayan, et al.
Publicado: (2019)

Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy
por: Park, Jihwan, et al.
Publicado: (2021)

Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
por: Chung, Jae Hoon, et al.
Publicado: (2021)

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy
por: Lin, Chia-Yen, et al.
Publicado: (2023)

AB056. Cytoreductive radical prostatectomy for men with oligo-metastatic prostate cancer
por: Liu, Shengjie, et al.
Publicado: (2017)

Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
por: Kelkar, Sonia, et al.
Publicado: (2021)

Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
por: Jin, Kun, et al.
Publicado: (2019)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
por: Wang, Li, et al.
Publicado: (2014)

Biochemical recurrence of pathological T2+ localized prostate cancer after robotic-assisted radical prostatectomy: A 10-year surveillance
por: Yang, Che Hseuh, et al.
Publicado: (2021)

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
por: Post, Jennifer M., et al.
Publicado: (2011)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

Prediction of biochemical recurrence after laparoscopic radical prostatectomy
por: Bejrananda, Tanan, et al.
Publicado: (2023)

Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
por: Shiraishi, Takumi, et al.
Publicado: (2011)

Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value
por: Chung, Jae Hoon, et al.
Publicado: (2022)

Biochemical failure after radical prostatectomy in intermediate-risk group men increases with the number of risk factors
por: Furubayashi, Nobuki, et al.
Publicado: (2017)

Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2019)

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
por: Autio, Karen A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b79tt5e7vdu01edc7db0b3j4gq